iGan Partners
iGan Partners is a Toronto-based venture capital firm founded in 2013 that invests at seed through Series A in AI-enabled MedTech and Digital Health companies in Canada, the US, and MENA. It supports 20+ portfolio companies with smart-capital, operator mentorship, and an industry co-investor network, and runs the US$250M iGan Arabia fund.
- Company typePrivate
- Founded2013
- HeadquartersToronto, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What iGan Partners does
iGan Partners is a Toronto-based venture capital firm founded in 2013 (with a first recorded portfolio investment in 2012) that invests at seed through Series A in AI-enabled MedTech and Digital Health companies. The firm is led by Founder & Managing Partner Sam Ifergan, with Dr. Lorena Tora serving as Chief Medical Officer and a small operator-investor team of 11-50 staff based at 60 Bloor Street West. Its 20+ portfolio companies include medical devices (ExactVu micro-ultrasound, MolecuLight fluorescence wound imaging, FloPatch wearable Doppler, eSight vision enhancement, Adenocyte LINFU), AI diagnostics (RetiSpec for Alzheimer's, Cosm Medical for women's health), data platforms (Segmed, Marble SettLiT), and confidential AI infrastructure (CyborgDB).
The firm's core technology proposition is not a product but a curated investment platform combining smart-capital with active portfolio support, domain-specific medical expertise, and access to a syndicate network of co-investors and industry partners. Portfolio companies deploy AI/ML in modalities including computer vision (MolecuLight, eSight, ExactVu), NLP-based PHI de-identification (Segmed on OpenAI's davinci), predictive analytics on retinal imagery (RetiSpec), and encrypted vector inference (CyborgDB).
iGan generates revenue primarily through management fees on its funds and carried interest from exits. The flagship Canadian/US fund is supplemented by the US$250M iGan Arabia regional fund launched in October 2022 with Faisal Belhoul to invest across the Middle East and North Africa. Distribution channels include a website pitch portal, direct founder outreach, industry referrals, the annual Pitch to Heal competition (awarding $600K), and strategic partnerships with Medical Alley (US pipeline), St. Andrews Medical Center and Previta (Mexico), and Quest Diagnostics (commercial lab access for portfolio products). The firm has documented at least one major exit (eSight acquired by Gentex in January 2024) and is actively deploying capital through 2025-2026.
iGan Partners firmographics
Firmographics- Name
- iGan Partners
- Legal name
- iGan Partners
- Website
- https://iganpartners.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- iGan Partners is a Toronto-based venture capital firm founded in 2013 that invests at seed through Series A in AI-enabled MedTech and Digital Health companies in Canada, the US, and MENA. It supports 20+ portfolio companies with smart-capital, operator mentorship, and an industry co-investor network, and runs the US$250M iGan Arabia fund.
- Ownership category
- akta.pro rank
iGan Partners industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Portfolio Management and Investment Advice (52394), All Other Financial Investment Activities (52399), Miscellaneous Financial Investment Activities (523999)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industries
- SDG / Thematic Sustainable Investment Funds (FSANAJAN), Geography-Focused Venture Capital (Regional/Emerging Markets) (FSANAAAE)
Keywords
Where iGan Partners is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
iGan Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Investment Returns: iGan Partners generates returns through capital appreciation and exits from portfolio companies. Returns come from IPOs, acquisitions, and secondary transactions. The firm has had successful exits including Fujifilm Visualsonics (IPO) and eSight (acquired by Gentex).
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
iGan Partners product offering
Product offeringCore offering
iGan Partners is a Canadian venture capital firm that invests seed and Series A capital in early-stage companies commercializing AI-enabled MedTech and Digital Health technologies. The firm provides portfolio companies with smart-capital, active support, and access to a network of industry partners and sector-specific co-investors to help them grow and achieve successful exits, including IPOs and strategic acquisitions.
Product overview
iGan Partners is a healthcare-focused venture capital firm that provides capital, active support, and access to a network of industry partners and sector-specific co-investors to early-stage companies in AI-enabled MedTech and Digital Health. iGan Partners does not offer its own proprietary product or service; rather, it supports portfolio companies that develop and commercialize distinct healthcare technology products. The portfolio includes medical devices (ExactVu micro-ultrasound system, MolecuLight i:X/DX fluorescence imaging devices, FloPatch wearable ultrasound, eSight Go vision enhancement glasses, Adenocyte LINFU system), AI diagnostics (RetiSpec AI eye test for Alzheimer's detection, Gynethotics AI-driven personalized gynecological devices), data platforms (Segmed medical imaging data platform, Marble SettLiT health data integration product), and AI infrastructure (CyborgDB confidential computing platform). These portfolio products address applications in cancer detection, wound care, hemodynamic monitoring, vision assistance, women's health, and healthcare data management.
Differentiator
Problem solved
Functional benefit
Products and services
- Seed-Stage Venture Capital Investment Equity capital and active support provided to early-stage healthcare startups from inception, including deal structure guidance and lead investment through every subsequent financing round.
- iGan Arabia Regional Fund US$250 million regional venture capital fund targeting AI/Cloud-enhanced medical devices and digital health technologies across the Middle East and North Africa (MENA) region, launched in partnership with Faisal Belhoul.
- Pitch to Heal Competition Annual competition awarding $600k investment to Canadian healthcare startups, held at Four Seasons Hotel in Toronto with over 200 attendees from the Canadian and international healthcare community.
Quantifiable outcome
- Multiple successful exits including Fujifilm Visualsonics (IPO) and eSight (acquired by Gentex)
- +1 more outcomes
Companies that use iGan Partners
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
iGan Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability15 records
iGan Partners partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered major and core.
- Quest DiagnosticsmajorNational laboratory services partnership for processing LINFU enhanced pancreatic cytology samples at Quest and AmeriPath laboratories in Tampa, Florida. Supports commercial expansion of Adenocyte's pancreatic cancer early detection platform.
- Medical AlleycoreStrategic partnership between iGan Partners and Medical Alley to accelerate development and adoption of pioneering medtech solutions. iGan Partners will work with Medical Alley Starts to identify, support, and scale innovative medical devices and digital health organizations. The partnership focuses on driving growth and scaling breakthrough technologies in healthcare through cross-border collaborations.
- Medical Alley StartscoreVenture platform under Medical Alley that accelerates formation and growth of startups. Partnership provides iGan Partners with early access to promising startup pipeline while providing portfolio companies with exceptional resources and strategic guidance.
- St. Andrews Medical CentercoreFirst entirely American medical center in Mexico, dedicated to implementing value-based healthcare and clinical evidence-based medical technology. Will dedicate space within facility for testing advanced medical devices and software to accelerate clinical trials and innovative healthcare deployments in Mexico, Canada, and US.
- PrevitacoreMexico's largest home healthcare services provider, joining forces to deliver high-quality healthcare services to patients' homes and hospitals via remote monitoring. Partnership aims to bridge gap in quality healthcare by leveraging preventive and treatment services combined with innovative technologies.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
iGan Partners competitors and assessment
Company assessmentBroad incumbents
- Optum Ventures: Optum's venture arm investing in healthcare and digital health startups. Larger and more established than iGan with strategic backing from UnitedHealth Group, but both focus on healthcare innovation at the growth stage.
- Andreessen Horowitz Bio Fund: Major US venture firm with dedicated healthcare and bio fund investing across stages. Substantially larger AUM than iGan with overlapping interest in AI-enabled healthcare and digital health, but operates at Series A and beyond rather than seed-stage Canadian focus.
- ARCH Venture Partners: Long-standing healthcare and biotech venture firm with deep expertise in early-stage healthcare investing. Comparable in sector specialization but typically operates at larger check sizes and later stages than iGan.
- Lux Capital: Tech and science-focused VC with significant healthcare investing. Comparable interest in healthcare AI and frontier tech, though broader sector mandate than iGan's pure healthcare focus.
- Khosla Ventures: Major US VC with significant healthcare and digital health investments alongside broader tech focus. Larger scale than iGan with overlapping thesis on AI-enabled healthcare transformation.
- General Catalyst: Large venture firm with a dedicated healthcare practice (Health Assurance) and significant digital health portfolio. Comparable healthcare focus but operates at much larger scale across multiple stages.
Direct peers
- Section32: Healthcare-focused venture fund investing in early-stage companies across digital health, medical devices, and AI diagnostics. Direct comparable in vertical specialization and stage focus, though US-based rather than Canadian.
- RA Capital Management: Healthcare-focused investment firm with both public and private equity strategies. Overlaps with iGan in clinical-stage healthcare investing but operates at larger scale and across both public and private markets.
- Early Stage Healthcare VCs (Seed-Series A focus): Comparable early-stage healthcare VCs include ARTIS Ventures, Civilization Ventures, and Health Catalyst Capital — firms that invest at seed/Series A in healthcare AI and digital health, similar stage and vertical focus as iGan Partners.
Regional players
- MaRS Discovery District: Toronto-based innovation hub supporting healthcare and tech startups with venture services. Regional comparable to iGan's Canadian healthcare startup ecosystem focus, though operates as an innovation hub rather than a dedicated VC fund.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
iGan Partners social profiles
Digital presenceiGan Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
iGan Partners leadership team
Management profileNumber of profiles
Profiles7 records
iGan Partners funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iGan Partners M&A and investment
M&A and investmentM&A
Investments46 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iGan Partners
What does iGan Partners do?
iGan Partners is a Canadian venture capital firm that invests seed and Series A capital in early-stage companies commercializing AI-enabled MedTech and Digital Health technologies. The firm provides portfolio companies with smart-capital, active support, and access to a network of industry partners and sector-specific co-investors to help them grow and achieve successful exits, including IPOs and strategic acquisitions.
Is iGan Partners a public or private company?
iGan Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was iGan Partners founded?
iGan Partners was founded in 2013. It employs 11 to 50 people.
Where is iGan Partners based?
iGan Partners is headquartered in Toronto, Canada, in the North America region.
How does iGan Partners make money?
One revenue line is on record: investment Returns.
Who are iGan Partners's main competitors?
Broad incumbents on record are Optum Ventures, Andreessen Horowitz Bio Fund, ARCH Venture Partners, Lux Capital, Khosla Ventures and General Catalyst. Direct peers are Section32, RA Capital Management and Early Stage Healthcare VCs (Seed-Series A focus). MaRS Discovery District is listed as a regional player.
Does iGan Partners have an API?
No public API is recorded for iGan Partners.
What industry is iGan Partners in?
iGan Partners's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAJAN, SDG / Thematic Sustainable Investment Funds. Its NAICS code is 52394 and its SIC code is 6282.